Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients

Oncology Reports

Volumn 31, Issue 1, 2014, Pages 351-357

  Gao, Feng ^a   Chang, Jingxia ^a   Wang, Huaqi ^a   Zhang, Guojun ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Biomarker; Lung adenocarcinoma; miR 155; Serum

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; MICRORNA 155;

ADULT; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STABLE EXPRESSION; YOUDEN INDEX;

ADENOCARCINOMA; CA-125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84892174853     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2830     Document Type: Article

References (23)

1. Nirasawa S, Kobayashi D, Tsuji N, Kuribayashi K and Watanabe N: Diagnostic relevance of overexpressed Nanog gene in early lung cancers. Oncol Rep 22: 587-591, 2009.
2. Duffy MJ: Role of tumor markers in patients with solid cancers: a critical review. Eur J Intern Med 18: 175-184, 2007.
3. Esquela-Kerscher A and Slack FJ: OncomiRs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
4. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
5. Soejima M, Tsuchiya Y, Egashira K, Kawano H, Sagawa K and Koda Y: Development and validation of a SYBR Green I - based real-time polymerase chain reaction method for detection of haptoglobin gene deletion in clinical materials. Transfusion 6: 1322-1327, 2010.
6. Alam MS, Mohon AN, Mustafa S, Khan WA, Islam N, Karim MJ, Khanum H, Sullivan DJ Jr and Haque R: Real-time PCR assay and rapid diagnostic tests for the diagnosis of clinically suspected malaria patients in Bangladesh. Malar J 10: 175, 2011.
7. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 9: e45, 2001.
8. Akobeng AK: Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 5: 644-647, 2007.
9. Galasso M, Sandhu SK and Volinia S: MicroRNA expression signatures in solid malignancies. Cancer J 3: 238-243, 2012.
10. Calin GA, Sevignani C, Dumitru CD, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004, 2004.
11. Farazi TA, Spitzer JI, Morozov P and Tuschl T: miRNAs in human cancer. J Pathol 2: 102-115, 2011.
12. Ambros V: MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 113: 673-676, 2003.
13. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
14. Keller A, Leidinger P, Borries A, Wendschlag A, Wucherpfennig F, Scheffler M, Huwer H, Lenhof HP and Meese E: miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 9: 353-363, 2009.
15. Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L, Weidhaas JB, Brown D, Bader AG and Slack FJ: The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 6: 759-764, 2008.
16. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436, 2008.
17. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM and Harris CC: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 3: 189-198, 2006.
18. Roa W, Brunet B, Guo L, Amanie J, Fairchild A, Gabos Z, Nijjar T, Scrimger R, Yee D and Xing J: Identification of a new microRNA expression profile as a potential cancer screening tool. Clin Invest Med 2: E124, 2010.
19. Grunnet M and Sorensen JB: Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer 2: 138-143, 2012.
20. Okamura K, Takayama K, Izumi M, Harada T, Furuyama K and Nakanishi Y: Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer. Lung Cancer 1: 45-49, 2013.
21. Li X, Asmitananda T, Gao L, Gai D, Song Z, Zhang Y, Ren H, Yang T, Chen T and Chen M: Biomarkers in the lung cancer diagnosis: a clinical perspective. Neoplasma 5: 500-507, 2012.
22. Demler OV, Pencina MJ and D'Agostino RB Sr: Equivalence of improvement in area under ROC curve and linear discriminant analysis coefficient under assumption of normality. Stat Med 12: 1410-1418, 2011.
23. Søreide K: Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research. J Clin Pathol 1: 1-5, 2009.